172 related articles for article (PubMed ID: 19143681)
21. Threshold serum concentrations of tumour necrosis factor alpha (TNFα) as a potential marker of the presence of microangiopathy in children and adolescents with type 1 diabetes mellitus (T1DM).
Zorena K; Kula M; Malinowska E; Raczyńska D; Myśliwiec M; Raczyńska K
Hum Immunol; 2013 Jan; 74(1):75-81. PubMed ID: 23073299
[TBL] [Abstract][Full Text] [Related]
22. Advanced glycation end products, soluble receptor for advanced glycation end products, and risk of colorectal cancer.
Jiao L; Taylor PR; Weinstein SJ; Graubard BI; Virtamo J; Albanes D; Stolzenberg-Solomon RZ
Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1430-8. PubMed ID: 21527578
[TBL] [Abstract][Full Text] [Related]
23. Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes.
Nakamura K; Yamagishi S; Adachi H; Kurita-Nakamura Y; Matsui T; Yoshida T; Imaizumi T
Mol Med; 2007; 13(3-4):185-9. PubMed ID: 17592553
[TBL] [Abstract][Full Text] [Related]
24. Soluble Receptor for Glycation End-products Concentration Increases Following the Treatment of Severe Diabetic Ketoacidosis.
Hoffman WH; Ishikawa T; Blum J; Tani N; Ikeda T; Artlett CM
J Clin Res Pediatr Endocrinol; 2020 Jun; 12(2):160-167. PubMed ID: 31514489
[TBL] [Abstract][Full Text] [Related]
25. Kinetics, role and therapeutic implications of endogenous soluble form of receptor for advanced glycation end products (sRAGE) in diabetes.
Yamagishi S; Matsui T; Nakamura K
Curr Drug Targets; 2007 Oct; 8(10):1138-43. PubMed ID: 17979674
[TBL] [Abstract][Full Text] [Related]
26. Action of metformin therapy against advanced glycation, oxidative stress and inflammation in type 2 diabetes patients: 3 months follow-up study.
Adeshara KA; Bangar NS; Doshi PR; Diwan A; Tupe RS
Diabetes Metab Syndr; 2020; 14(5):1449-1458. PubMed ID: 32769032
[TBL] [Abstract][Full Text] [Related]
27. Soluble receptor for advanced glycation end products (sRAGE) and endogenous secretory RAGE (esRAGE) in amniotic fluid: modulation by infection and inflammation.
Romero R; Espinoza J; Hassan S; Gotsch F; Kusanovic JP; Avila C; Erez O; Edwin S; Schmidt AM
J Perinat Med; 2008; 36(5):388-98. PubMed ID: 18593373
[TBL] [Abstract][Full Text] [Related]
28. Serum soluble receptor for advanced glycation end products correlates inversely with measures of adiposity in young adults.
Davis KE; Prasad C; Vijayagopal P; Juma S; Imrhan V
Nutr Res; 2014 Jun; 34(6):478-85. PubMed ID: 25026914
[TBL] [Abstract][Full Text] [Related]
29. Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes.
Kopytek M; Ząbczyk M; Mazur P; Undas A; Natorska J
Cardiovasc Diabetol; 2020 Jun; 19(1):92. PubMed ID: 32552684
[TBL] [Abstract][Full Text] [Related]
30. [The frequency of mild and severe fetal malformations in diabetic women with high values of glycosilated hemoglobin in early pregnancy].
Todorova K; Mazneĭkova V; Ivanov S; Genova M
Akush Ginekol (Sofiia); 2005; 44(3):3-10. PubMed ID: 16028383
[TBL] [Abstract][Full Text] [Related]
31. Association analysis of -429T/C receptor for advanced glycation end products (RAGE) gene polymorphism with type 2 diabetic retinopathy and serum soluble RAGE levels in Pakistani patients.
Qayyum S; Afzal M; Naveed AK
J Pak Med Assoc; 2021 Apr; 71(4):1175-1180. PubMed ID: 34125766
[TBL] [Abstract][Full Text] [Related]
32. Serum levels of advanced glycation end products (AGEs) are increased and their soluble receptor (sRAGE) reduced in Hashimoto's thyroiditis.
Ruggeri RM; Barbalace MC; Cristani MT; Alibrandi A; Giovinazzo S; Giuffrida G; Trimarchi F; Cannavò S; Campennì A
J Endocrinol Invest; 2020 Sep; 43(9):1337-1342. PubMed ID: 32232775
[TBL] [Abstract][Full Text] [Related]
33. Levels of soluble advanced glycation end product-receptors and other soluble serum markers as indicators of diabetic neuropathy in the foot.
El-Mesallamy HO; Hamdy NM; Ezzat OA; Reda AM
J Investig Med; 2011 Dec; 59(8):1233-8. PubMed ID: 21941211
[TBL] [Abstract][Full Text] [Related]
34. Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications.
Katakami N; Matsuhisa M; Kaneto H; Matsuoka TA; Sakamoto K; Nakatani Y; Ohtoshi K; Hayaishi-Okano R; Kosugi K; Hori M; Yamasaki Y
Diabetes Care; 2005 Nov; 28(11):2716-21. PubMed ID: 16249545
[TBL] [Abstract][Full Text] [Related]
35. Serum soluble receptor for advanced glycation end products (sRAGE) is independently associated with cigarette smoking in non-diabetic healthy subjects.
Biswas SK; Mudi SR; Mollah FH; Bierhaus A; Arslan MI
Diab Vasc Dis Res; 2013 Jul; 10(4):380-2. PubMed ID: 23520177
[TBL] [Abstract][Full Text] [Related]
36. Protective mechanisms against oxidative stress and angiopathy in young patients with diabetes type 1 (DM1).
Koutroumani N; Partsalaki I; Lamari F; Dettoraki A; Gil AP; Karvela A; Kostopoulou E; Spiliotis BE
J Pediatr Endocrinol Metab; 2013; 26(3-4):309-17. PubMed ID: 23337054
[TBL] [Abstract][Full Text] [Related]
37. Soluble RAGE, diabetic nephropathy and genetic variability in the AGER gene.
Kanková K; Kalousová M; Hertlová M; Krusová D; Olsovský J; Zima T
Arch Physiol Biochem; 2008 Apr; 114(2):111-9. PubMed ID: 18615900
[TBL] [Abstract][Full Text] [Related]
38. Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects.
Yamagishi S; Adachi H; Nakamura K; Matsui T; Jinnouchi Y; Takenaka K; Takeuchi M; Enomoto M; Furuki K; Hino A; Shigeto Y; Imaizumi T
Metabolism; 2006 Sep; 55(9):1227-31. PubMed ID: 16919543
[TBL] [Abstract][Full Text] [Related]
39. Decrease in circulating concentrations of soluble receptors for advanced glycation end products at the time of seroconversion to autoantibody positivity in children with prediabetes.
Salonen KM; Ryhänen SJ; Forbes JM; Borg DJ; Härkönen T; Ilonen J; Simell O; Veijola R; Groop PH; Knip M
Diabetes Care; 2015 Apr; 38(4):665-70. PubMed ID: 25573878
[TBL] [Abstract][Full Text] [Related]
40. Soluble receptor for advanced glycation end products in physiological and pathological pregnancy.
Germanová A; Koucký M; Hájek Z; Parízek A; Zima T; Kalousová M
Clin Biochem; 2010 Mar; 43(4-5):442-6. PubMed ID: 19909734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
